Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment

doi:10.3748/wjg.v27.i46.7943

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 46

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4503)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

335

WORD

HTML

2368

Figures (1-1)

207

Tables (1-1)

235

Sum=3230

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

383

Download

890

Sum=1273

Dec 14, 2021 (publication date) through May 24, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Dec 14, 2021; 27(46): 7943-7955
Published online Dec 14, 2021. doi: 10.3748/wjg.v27.i46.7943

Open in New Tab Full Size Figure Download Figure

Figure 1 Coronavirus disease 2019 induced inflammatory bowel diseases mechanism. ADAM17: A disintegrin and metalloprotease domain 17; ACE2: Angiotensin-converting enzyme 2; TMPRSS2: Transmembrane serine protease 2; SARS-Cov-2: Severe acute respiratory syndrome coronavirus 2; GCSF: Granulocyte colony-stimulating factor; IP-10: Interferon gamma-induced protein 10; MCP1: Monocyte chemoattractant protein 1; MIP1-α: Macrophage inflammatory proteins-α; IBD: Inflammatory bowel diseases.

Citation: Lashgari NA, Momeni Roudsari N, Momtaz S, Abdolghaffari AH. Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment. World J Gastroenterol 2021; 27(46): 7943-7955
URL: https://www.wjgnet.com/1007-9327/full/v27/i46/7943.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i46.7943